News, insight, events and case studies
-
Insight
Bringing the customer experience into the heart of CliniSys
Wayne Tainton is a solutions manager at CliniSys; but until the summer of 2022 he was a pathology IT manager in Bristol. His move underlines CliniSys’ commitment to working with its customers and to using their experience to make sure that its systems address the challenges they are facing.
2 August 2022
-
Insight
How Your Laboratory Can Overcome Labor Shortages
The labor shortages still sweeping the US and other parts of the world extend to the laboratory space as well. The laboratory industry was already short on qualified people to fill the key roles. On top of that, pre-existing worker shortage, the laboratory testing industry has demanded a lot of its personnel over the last […]
24 June 2022
-
Insight
How to Use Autoverification in the Laboratory to Improve Efficiency
Kim Futrell, MT(ASCP), MSHI Lab Stewardship, LIS Using your laboratory information system (LIS) for autoverification is one of the most effective ways your lab can reduce hands-on tech time through process automation. Depending on the lab menu and patient population, 40% to 95% of results could qualify for autoverification.1,2 What is autoverification? Autoverification is a […]
9 May 2022
-
Insight
Human genetics and molecular Diagnostics: Innovative solutions for constantly changing requirements
As the rapid pace of development in human genetics and molecular diagnostics continues unabated, it's worth asking whether traditional laboratory information systems (LIS) are still capable of meeting current requirements in these fields
20 January 2022
-
Insight
Developments in Diagnostics: Strengthen Your Lab’s Business Model
As we reflect on 2021, the ApolloLIMS team has noticed some interesting developments in the diagnostics space. The combination of the COVID-19 pandemic along with some other general developments within the biotech sector overall have combined to impact the diagnostic space for the better. The last year has been an exciting time to partner with […]
14 December 2021
-
Insight
Looking back, moving forward
We review 2021 and considers how the ongoing impact of Covid-19 and the rapid formation of pathology networks will impact the company in 2022. He also pauses to unwrap a ‘Christmas present’; the VUE diagnostic console that enables clinicians to report and view test results alongside many other sources of patient information.
9 December 2021
-
Insight
LabPinnacle 2 – Beyond LIMS: The Value of Coordinated Orders and Results Management
The Value of Coordinated Orders and Results Management for Outreach & Ambulatory Laboratory Testing. Extending lab reach beyond hospital walls works best with the integration of specialized surrounding solutions.
11 October 2021
-
Insight
Introducing GLIMS Genetics Counselling
In 2019, CliniSys | MIPS launched its Genetics LIS, with a successful phase of development and deployment in Europe. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genetics Counselling to clinicians, laboratories, patients and their families.
28 September 2021
-
Insight
5 Ways to Improve POCT ROI
Kim Futrell, MT(ASCP), MSHI Get more benefits from your point-of-care testing (POCT) program The advantage of quick test results to enable faster clinical decisions is one of the major reasons to implement point-of-care testing (POCT). At a time when hospitals and laboratories are under intense pressure, the benefits of patients accessing tests outside the traditional […]
30 August 2021
-
Insight
Introducing GLIMS Genomics Clinical
Last year, CliniSys brought its genomics LIMS to the UK, following a successful phase of development and deployment on the continent. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genomics Clinical to clinicians, laboratories, patients and their families
16 August 2021
-
Insight
COVID-19 Diagnostic Testing — Moving to the Point-of-Care: Part 2 in a Series
In our Part 1 of this blog series, we discussed the changes we are anticipating in the centralized testing model for COVID-19. There are some changes in store for the COVID-19 diagnostics market driven by the increase in the number of recent authorizations by the US Food and Drug Administration (FDA) for point-of-care (and point of need) […]
17 June 2021
-
Insight
The Changing Landscape of COVID-19 — What’s Next? Part 1 in a Series
The United States is reaching a transition point in the COVID-19 pandemic due to a rise in the SARS-CoV-2-immune population (via vaccination or infection) and the onset of warmer weather. As a result, the COVID-19 cases in the United States are expected to decrease over the next few months. However, this year’s autumn and winter […]
9 June 2021